vs

Side-by-side financial comparison of CME Group (CME) and UGI CORP (UGI). Click either name above to swap in a different company.

UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.9B, roughly 1.1× CME Group). UGI CORP runs the higher net margin — 14.4% vs 0.1%, a 14.3% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 3.9%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -7.5%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.

CME vs UGI — Head-to-Head

Bigger by revenue
UGI
UGI
1.1× larger
UGI
$2.1B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+10.6% gap
CME
14.5%
3.9%
UGI
Higher net margin
UGI
UGI
14.3% more per $
UGI
14.4%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-7.5%
UGI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
UGI
UGI
Revenue
$1.9B
$2.1B
Net Profit
$1.2M
$297.0M
Gross Margin
Operating Margin
0.1%
22.0%
Net Margin
0.1%
14.4%
Revenue YoY
14.5%
3.9%
Net Profit YoY
20.7%
-20.8%
EPS (diluted)
$1.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
UGI
UGI
Q1 26
$1.9B
Q4 25
$1.6B
$2.1B
Q3 25
$1.5B
$1.2B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
$2.6B
Q4 24
$1.5B
$2.0B
Q3 24
$1.6B
$1.2B
Q2 24
$1.5B
$1.4B
Net Profit
CME
CME
UGI
UGI
Q1 26
$1.2M
Q4 25
$1.2B
$297.0M
Q3 25
$908.0M
$-13.0M
Q2 25
$1.0B
$-163.0M
Q1 25
$956.2M
$479.0M
Q4 24
$874.6M
$375.0M
Q3 24
$912.8M
$-273.0M
Q2 24
$883.2M
$-48.0M
Operating Margin
CME
CME
UGI
UGI
Q1 26
0.1%
Q4 25
61.8%
22.0%
Q3 25
63.3%
1.1%
Q2 25
66.7%
-6.8%
Q1 25
67.5%
26.6%
Q4 24
62.1%
24.5%
Q3 24
64.6%
-20.4%
Q2 24
65.3%
5.0%
Net Margin
CME
CME
UGI
UGI
Q1 26
0.1%
Q4 25
71.7%
14.4%
Q3 25
59.1%
-1.1%
Q2 25
60.6%
-12.0%
Q1 25
58.2%
18.2%
Q4 24
57.3%
18.9%
Q3 24
57.6%
-22.6%
Q2 24
57.6%
-3.6%
EPS (diluted)
CME
CME
UGI
UGI
Q1 26
Q4 25
$3.24
$1.34
Q3 25
$2.49
$-0.08
Q2 25
$2.81
$-0.76
Q1 25
$2.62
$2.19
Q4 24
$2.40
$1.74
Q3 24
$2.50
$-1.26
Q2 24
$2.42
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
UGI
UGI
Cash + ST InvestmentsLiquidity on hand
$2.4B
$251.0M
Total DebtLower is stronger
$3.4B
$6.0B
Stockholders' EquityBook value
$5.0B
Total Assets
$202.0B
$15.8B
Debt / EquityLower = less leverage
1.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
UGI
UGI
Q1 26
$2.4B
Q4 25
$4.5B
$251.0M
Q3 25
$2.6B
$335.0M
Q2 25
$2.1B
$350.0M
Q1 25
$1.5B
$426.0M
Q4 24
$3.0B
$240.0M
Q3 24
$2.4B
$213.0M
Q2 24
$1.9B
$183.0M
Total Debt
CME
CME
UGI
UGI
Q1 26
$3.4B
Q4 25
$6.0B
Q3 25
$6.5B
Q2 25
$5.7B
Q1 25
$6.6B
Q4 24
$6.6B
Q3 24
$6.4B
Q2 24
$6.3B
Stockholders' Equity
CME
CME
UGI
UGI
Q1 26
Q4 25
$28.7B
$5.0B
Q3 25
$28.2B
$4.8B
Q2 25
$27.7B
$4.9B
Q1 25
$27.0B
$5.0B
Q4 24
$26.5B
$4.6B
Q3 24
$28.2B
$4.3B
Q2 24
$27.6B
$4.7B
Total Assets
CME
CME
UGI
UGI
Q1 26
$202.0B
Q4 25
$198.4B
$15.8B
Q3 25
$187.1B
$15.5B
Q2 25
$179.9B
$15.4B
Q1 25
$157.8B
$15.7B
Q4 24
$137.4B
$15.4B
Q3 24
$137.8B
$15.1B
Q2 24
$123.4B
$15.1B
Debt / Equity
CME
CME
UGI
UGI
Q1 26
Q4 25
1.19×
Q3 25
1.37×
Q2 25
1.17×
Q1 25
1.32×
Q4 24
1.44×
Q3 24
1.48×
Q2 24
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
UGI
UGI
Operating Cash FlowLast quarter
$66.0M
Free Cash FlowOCF − Capex
$-155.0M
FCF MarginFCF / Revenue
-7.5%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$282.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
UGI
UGI
Q1 26
Q4 25
$1.1B
$66.0M
Q3 25
$968.1M
$90.0M
Q2 25
$1.1B
$289.0M
Q1 25
$1.1B
$684.0M
Q4 24
$1.0B
$164.0M
Q3 24
$1.0B
$151.0M
Q2 24
$776.9M
$390.0M
Free Cash Flow
CME
CME
UGI
UGI
Q1 26
Q4 25
$1.1B
$-155.0M
Q3 25
$949.7M
$-168.0M
Q2 25
$1.0B
$67.0M
Q1 25
$1.1B
$538.0M
Q4 24
$991.7M
$-47.0M
Q3 24
$973.2M
$-115.0M
Q2 24
$758.7M
$185.0M
FCF Margin
CME
CME
UGI
UGI
Q1 26
Q4 25
66.8%
-7.5%
Q3 25
61.8%
-14.4%
Q2 25
61.5%
4.9%
Q1 25
67.1%
20.4%
Q4 24
65.0%
-2.4%
Q3 24
61.4%
-9.5%
Q2 24
49.5%
13.7%
Capex Intensity
CME
CME
UGI
UGI
Q1 26
Q4 25
2.0%
10.7%
Q3 25
1.2%
22.1%
Q2 25
1.1%
16.3%
Q1 25
0.9%
5.5%
Q4 24
1.7%
10.6%
Q3 24
1.9%
22.0%
Q2 24
1.2%
15.2%
Cash Conversion
CME
CME
UGI
UGI
Q1 26
Q4 25
0.96×
0.22×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
1.43×
Q4 24
1.16×
0.44×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons